Tag Archives: Spain

Spanish Generics Industry to Government: "Leave Branded Pharma Alone"

By Guest Blogger | Published: October 24, 2012
Just days before the reports that R&D investment in Spanish pharma had fallen to below EUR1 billion ($1.3 billion) in 2011 for the first time since 2007, the country’s generic manufacturers association, AESEG, offered some unexpected support for the branded industry. In comments to APM Health Europe described as “rare”, AESEG chief Ángel Luis Rodríguez de [...]
Posted in Europe, Global, healthcare | Also tagged , , , , , | Leave a comment

Election Landslide: What Now for Spanish Healthcare?

By Julian Upton | Published: November 22, 2011
The fact that the eurozone is in a tailspin is hardly ‘news’, but when heads start rolling as fast as they have done recently in Greece, Italy, and now Spain, it leaves the unsettling feeling that the heat on an already intense situation has been turned up one more notch.
Posted in Europe, healthcare | Also tagged , , , | 1 Comment

The Pain in Spain

By Guest Blogger | Published: February 16, 2011
The pain of the Spanish drug-spending squeeze extends way beyond the plain, says Reflector. The cries of anguish at Spanish drug-spending squeezes are coming not only from Madrid, but from many of the autonomous regions around the periphery of the country too. After almost a decade of continual disruption and downward pressure on pricing, the medicines industry [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , | 2 Comments

Europe’s Fiscal Crisis: Can Big Pharma Emerge Unscathed?

By William Looney | Published: June 2, 2010
Europe’s current fiscal crisis, symbolized by the meltdown in Greece, is seen by big pharma as a temporary situation to be taken in stride—after all, the EU southern and eastern tier, with its chronically shaky finances and per capita incomes as low as a third of the EU norm, has historically been a marginal player [...]
Posted in Europe | Also tagged , , , , , | 2 Comments